Prolonged infusion of angiotensin II into normal rats induces stellate cell activation and proinflammatory events in liver
- PMID: 12773299
- DOI: 10.1152/ajpgi.00037.2003
Prolonged infusion of angiotensin II into normal rats induces stellate cell activation and proinflammatory events in liver
Abstract
Recent evidence indicates that angiotensin II (ANG II) plays an important role in liver fibrogenesis. However, the underlying mechanisms are largely unknown. In advanced chronic liver diseases, circulating levels of ANG II are frequently elevated. We investigated the hepatic effects of prolonged systemic infusion of ANG II in normal rats. Saline or ANG II at subpressor and pressor doses (15 and 50 ng.kg-1.min-1, respectively) were infused to normal rats for 4 wk through a subcutaneous osmotic pump. Infusion of ANG II resulted in liver injury, as assessed by elevated serum liver enzymes. Livers from ANG II-perfused rats showed activation of JNK and ERK as well as increased NF-kappaB and activating protein-1 DNA-binding activity. Moreover, ANG II perfusion induced oxidative stress, increased concentration of proinflammatory cytokines, and upregulated the inflammatory proteins inducible nitric oxide synthase and cyclooxygenase-2. Histological examination of the livers from ANG II-infused rats showed mild portal inflammation as well as thickening and thrombosis of small hepatic vessels. ANG II-treated livers showed accumulation of CD43-positive inflammatory cells and activated hepatic stellate cells (HSCs) at the pericentral areas. A slight increase in collagen synthesis was observed, as assessed by Sirius red staining and hepatic hydroxyproline. All of these effects were observed when ANG II was perfused at subpressor and pressor doses. ANG II also accelerated the activation of primary cultured rat HSCs. In conclusion, increased systemic ANG II can induce liver injury by promoting proinflammatory events and vascular damage. ANG II-induced hepatic effects are not dependent on increase in arterial pressure.
Similar articles
-
Atorvastatin attenuates angiotensin II-induced inflammatory actions in the liver.Am J Physiol Gastrointest Liver Physiol. 2009 Feb;296(2):G147-56. doi: 10.1152/ajpgi.00462.2007. Epub 2008 Dec 4. Am J Physiol Gastrointest Liver Physiol. 2009. PMID: 19056767
-
Systemic infusion of angiotensin II exacerbates liver fibrosis in bile duct-ligated rats.Hepatology. 2005 May;41(5):1046-55. doi: 10.1002/hep.20665. Hepatology. 2005. PMID: 15841463
-
Angiotensin II regulates the synthesis of proinflammatory cytokines and chemokines in the kidney.Kidney Int Suppl. 2002 Dec;(82):S12-22. doi: 10.1046/j.1523-1755.62.s82.4.x. Kidney Int Suppl. 2002. PMID: 12410849
-
Nitric oxide synthase inhibition accelerates the pressor response to low-dose angiotensin II, exacerbates target organ damage, and induces renin escape.Am J Hypertens. 2004 May;17(5 Pt 1):395-403. doi: 10.1016/j.amjhyper.2004.01.003. Am J Hypertens. 2004. PMID: 15110897
-
Development of hypertension induced by subpressor infusion of angiotensin II: role of sensory nerves.Hypertension. 2000 Oct;36(4):549-52. doi: 10.1161/01.hyp.36.4.549. Hypertension. 2000. PMID: 11040234
Cited by
-
Alcoholic liver disease and the potential role of plasminogen activator inhibitor-1 and fibrin metabolism.Exp Biol Med (Maywood). 2012 Jan;237(1):1-9. doi: 10.1258/ebm.2011.011255. Exp Biol Med (Maywood). 2012. PMID: 22238286 Free PMC article. Review.
-
Effects of losartan on hepatic expression of nonphagocytic NADPH oxidase and fibrogenic genes in patients with chronic hepatitis C.Am J Physiol Gastrointest Liver Physiol. 2009 Oct;297(4):G726-34. doi: 10.1152/ajpgi.00162.2009. Epub 2009 Jul 23. Am J Physiol Gastrointest Liver Physiol. 2009. PMID: 19628656 Free PMC article. Clinical Trial.
-
The effects of angiotensin blocking agents on the progression of liver fibrosis in the HALT-C Trial cohort.Dig Dis Sci. 2011 Feb;56(2):564-8. doi: 10.1007/s10620-010-1507-8. Epub 2010 Dec 7. Dig Dis Sci. 2011. PMID: 21136163 Free PMC article. Clinical Trial.
-
Sinusoidal endothelial dysfunction precedes inflammation and fibrosis in a model of NAFLD.PLoS One. 2012;7(4):e32785. doi: 10.1371/journal.pone.0032785. Epub 2012 Apr 3. PLoS One. 2012. PMID: 22509248 Free PMC article.
-
Aliskiren attenuates steatohepatitis and increases turnover of hepatic fat in mice fed with a methionine and choline deficient diet.PLoS One. 2013 Oct 21;8(10):e77817. doi: 10.1371/journal.pone.0077817. eCollection 2013. PLoS One. 2013. PMID: 24204981 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous